MedPath

Dexamethasone

Generic Name
Dexamethasone
Brand Names
Baycadron, Ciprodex, Decadron, Dexamethasone Intensol, Dextenza, Dioptrol, Hexadrol, Hidex 6-day Taper, Maxidex, Maxitrol, Neofordex, Ozurdex, Taperdex 12 Day Taper, Taperdex 6 Day Taper, Taperdex 7-day Taper, Tobradex, Zcort 7 Day Taper
Drug Type
Small Molecule
Chemical Formula
C22H29FO5
CAS Number
50-02-2
Unique Ingredient Identifier
7S5I7G3JQL
Background

Dexamethasone, or MK-125, is a corticosteroid fluorinated at position 9 used to treat endocrine, rheumatic, collagen, dermatologic, allergic, ophthalmic, gastrointestinal, respiratory, hematologic, neoplastic, edematous, and other conditions. Developed in 1957, it is structurally similar to other corticosteroids like hydrocortisone and prednisolone.

Dexamethasone was granted FDA approval on 30 October 1958. In a press release for the Randomized Evaluation of COVID-19 Therapy (RECOVERY) trial on 16 June 2020, dexamethasone was recommended for use in COVID-19 patients with severe respiratory symptoms. Dexamethasone reduced deaths by approximately one third in patients requiring ventilation and by one fifth in those requiring oxygen.

Indication

Dexamethasone and ciprofloxacin otic suspension is indicated for bacterial infections with inflammation in acute otitis media and acute otitis externa. Intramuscular and intravenous injections are indicated for a number of endocrine, rheumatic, collagen, dermatologic, allergic, ophthalmic, gastrointestinal, respiratory, hematologic, neoplastic, edematous, and other conditions. Oral tablets are indicated for the treatment of multiple myeloma. An intravitreal implant is indicated for some forms of macular edema and non-infectious posterior uveitis affecting the posterior of the eye. Various ophthalmic formulations are indicated for inflammatory conditions of the eye.

Associated Conditions
Acute Gouty Arthritis, Acute Leukemia, Acute Otitis Externa, Acute Otitis Media (AOM), Adrenocortical Hyperfunction, Adrenocortical Insufficiency, Allergic Conjunctivitis (AC), Alopecia Areata (AA), Ankylosing Spondylitis (AS), Aspiration Pneumonitis, Asthma, Atopic Dermatitis, Berylliosis, Bullous dermatitis herpetiformis, Bursitis, Chorioretinitis, Choroiditis, Congenital Adrenal Hyperplasia (CAH), Congenital Hypoplastic Anemia, Conjunctivitis, Contact Dermatitis, Cushing's Syndrome, Dermatitis, Diabetic Macular Edema (DME), Discoid Lupus Erythematosus (DLE), Drug hypersensitivity reaction, Edema of the cerebrum, Epicondylitis, Episcleritis, Erythroblastopenia, Eye Infections, Eye allergy, Glaucoma, Hypercalcemia, Immune Thrombocytopenia (ITP), Infection, Inflammation, Inflammation of the External Auditory Canal, Intraocular Inflammation, Iridocyclitis, Iritis, Keloids Scars, Keratitis, Lichen Planus (LP), Lichen simplex chronicus, Loeffler's syndrome, Lymphoma, Macular Edema, Meningitis caused by Mycobacterium Tuberculosis, Middle ear inflammation, Mucosal Inflammation of the eye, Multiple Myeloma (MM), Muscle Inflammation caused by Cataract Surgery of the eye, Mycosis Fungoides (MF), Necrobiosis lipoidica diabeticorum, Non-infectious Posterior Uveitis, Ocular Infections, Irritations and Inflammations, Ocular Inflammation, Ocular Inflammation and Pain, Ocular Irritation, Ocular Itching, Ophthalmia, Sympathetic, Optic Neuritis, Otitis Externa, Pemphigus, Perennial Allergic Rhinitis (PAR), Phlyctenular keratoconjunctivitis, Postoperative Infections of the eyes caused by susceptible bacteria, Posttraumatic Osteoarthritis, Regional Enteritis, Rheumatoid Arthritis, Rheumatoid Arthritis, Juvenile, Rosacea, Sarcoidosis, Scleritis, Seasonal Allergic Rhinitis, Secondary thrombocytopenia, Serum Sickness, Severe Seborrheic Dermatitis, Stevens-Johnson Syndrome, Synovitis, Systemic Lupus Erythematosus, Tenosynovitis, Trichinosis, Tuberculosis (TB), Ulcerative Colitis, Uveitis, Vernal Keratoconjunctivitis, Acquired immune hemolytic anemia, Acute rheumatic carditis, Anterior eye segment inflammation, Corticosteroid-responsive dermatoses, Ear infection-not otherwise specified caused by susceptible bacteria, Exfoliative erythroderma, Granuloma annulare lesions, Non-suppurative Thyroiditis, Ocular bacterial infections, Severe Psoriasis, Steroid-responsive inflammation of the eye, Swelling of the eyes, Varicella-zoster virus acute retinal necrosis, Watery itchy eyes
Associated Therapies
-

Effect of Intracameral Dexamethasone After Phacoemulsification in Diabetics on Corneal Endothelial Cell Density

Phase 4
Withdrawn
Conditions
Corneal Endothelial Decompensation
Diabetes Mellitus
Corneal Endothelial Cell Loss
Dexamethasone Adverse Reaction
Interventions
Drug: Saline Solutions, Intraocular
Drug: Dexamethasone
First Posted Date
2017-12-05
Last Posted Date
2019-07-24
Lead Sponsor
Cairo University
Registration Number
NCT03361709

Pevonedistat With VXLD Chemotherapy for Adolescent/Young Adults With Relapsed/Refractory ALL or Lymphoblastic NHL

Phase 1
Completed
Conditions
Refractory Acute Lymphoblastic Leukemia
Relapsed Acute Lymphoblastic Leukemia
Interventions
First Posted Date
2017-11-21
Last Posted Date
2022-10-20
Lead Sponsor
Julio Barredo, MD
Target Recruit Count
6
Registration Number
NCT03349281
Locations
🇺🇸

University of Miami, Miami, Florida, United States

Spectroscopic and Diffusion Weighted Analysis of the Effects of Dexamethasone on High Altitude Cerebral Oedema (HACE)

Phase 1
Completed
Conditions
High Altitude Cerebral Edema
Interventions
Drug: Placebo
Drug: Dexamethasone
First Posted Date
2017-11-14
Last Posted Date
2024-06-18
Lead Sponsor
University Hospitals Coventry and Warwickshire NHS Trust
Target Recruit Count
10
Registration Number
NCT03341676
Locations
🇬🇧

University Hospitals Coventry and Warwickshire NHS Trust, Coventry, West Midlands, United Kingdom

QLB and Laparoscopic Nephrectomy, Postoperative Pain and Recovery

Phase 4
Conditions
Postoperative Pain
Chronic Pain Post-Proceduraal
Nausea and Vomiting, Postoperative
Interventions
First Posted Date
2017-11-13
Last Posted Date
2021-12-23
Lead Sponsor
Tampere University Hospital
Target Recruit Count
90
Registration Number
NCT03339284
Locations
🇫🇮

Tampere University Hospital, Tampere, Finland

Dexamethasone Administration To Improve Patient Recovery In Ambulatory Vaginal Prolapse Surgery: Is There A Role?

Phase 2
Completed
Conditions
Quality of Recovery
Same Day Surgery
Nausea and Vomiting, Postoperative
Vaginal Prolapse
Interventions
Drug: Normal saline
Drug: Dexamethasone
First Posted Date
2017-11-09
Last Posted Date
2021-04-14
Lead Sponsor
The Cleveland Clinic
Target Recruit Count
51
Registration Number
NCT03338400
Locations
🇺🇸

Cleveland Clinic Florida, Weston, Florida, United States

Carfilzomib, Cyclophosphamide, Dexamethasone in Multiple Myeloma

Phase 2
Active, not recruiting
Conditions
Multiple Myeloma
Interventions
First Posted Date
2017-11-08
Last Posted Date
2022-09-07
Lead Sponsor
PETHEMA Foundation
Target Recruit Count
199
Registration Number
NCT03336073
Locations
🇪🇸

Hospital de León, León, Spain

🇪🇸

H. Ramón y Cajal, Madrid, Spain

🇪🇸

Hospital Universitario de Santiago, Santiago De Compostela, Spain

and more 21 locations

Study Evaluating the Safety of Rovalpituzumab Tesirine for Third-Line and Later Treatment of Subjects With Relapsed or Refractory Small Cell Lung Cancer

Phase 3
Withdrawn
Conditions
Small Cell Lung Cancer
Interventions
First Posted Date
2017-11-07
Last Posted Date
2018-12-26
Lead Sponsor
AbbVie
Registration Number
NCT03334487
Locations
🇺🇸

VA Central California Health C /ID# 170951, Fresno, California, United States

🇺🇸

St. Luke's University Hospital /ID# 171374, Duluth, Minnesota, United States

🇧🇷

Bahia Oncology Center - NOB /ID# 201272, Salvador, Bahia, Brazil

and more 57 locations

Effect of Perineural Dexamethasone on the Duration of Popliteal Nerve Block for Anesthesia After Ankle Surgery

Phase 4
Completed
Conditions
Postoperative Pain
Nerve Block
Interventions
First Posted Date
2017-11-06
Last Posted Date
2023-11-28
Lead Sponsor
Tampere University Hospital
Target Recruit Count
84
Registration Number
NCT03332316
Locations
🇫🇮

Tampere University Hospital, Tampere, Finland

Study of Hyperthermic Intraperitoneal Chemoperfusion (HIPEC) in Patients With Gastric Adenocarcinoma and Carcinomatosis or Positive Cytology

Phase 1
Completed
Conditions
Diseases of Oesophagus Stomach and Duodenum
Interventions
First Posted Date
2017-11-06
Last Posted Date
2023-04-21
Lead Sponsor
M.D. Anderson Cancer Center
Target Recruit Count
29
Registration Number
NCT03330028
Locations
🇺🇸

University of Texas MD Anderson Cancer Center, Houston, Texas, United States

An Evaluation of Blood Glucose Levels and Insulin Requirement After Subacromial Corticosteroid Injection in Insulin Dependent Diabetics

Not Applicable
Withdrawn
Conditions
Shoulder Injury
Insulin-dependent Diabetics
Interventions
Other: Placebo
Drug: Dexamethasone
First Posted Date
2017-11-01
Last Posted Date
2017-11-01
Lead Sponsor
University of Pittsburgh
Registration Number
NCT03328975
© Copyright 2025. All Rights Reserved by MedPath